Clinical evidence from ONTARGET: proven cardio- and vascular protection Conferences

authors

• Teo, Koon

status

• published 

publication date

• December 1, 2009

has subject area

• 1102 Cardiorespiratory Medicine and Haematology (FoR)
• Cardiovascular System & Hematology (Science Metrix)

published in

• European Heart Journal, Supplement  Journal

presented at event

• Annual Congress of the European-Society-of-Cardiology  Conference

keywords

• ANGIOTENSIN-II
• Angiotensin II receptor blockers
• Angiotensin-converting enzyme inhibitors
• CARDIOVASCULAR EVENTS
• CHRONIC HEART-FAILURE
• CONVERTING-ENZYME-INHIBITORS
• Cardiac & Cardiovascular Systems
• Cardiovascular System & Cardiology
• DOUBLE-BLIND
• LEFT-VENTRICULAR DYSFUNCTION
• Life Sciences & Biomedicine
• ONTARGET
• PATIENTS INTOLERANT
• RANDOMIZED TRIAL
• RECEPTOR BLOCKER
• Ramipril
• SYSTOLIC FUNCTION
• Science & Technology
• Telmisartan

Digital Object Identifier (DOI)

• 10.1093/eurheartj/sup032

start page

• F9

end page

• F15

volume

• 11

issue

• Suppl F